Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Navarro, M. Perez, D. Hernandez, E. Ansotegui, M. Cebrian, J. Peman, A. Sole (Valencia, Spain). Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment. Eur Respir J 2012; 40: Suppl. 56, 3380

Member's Comments

No comment yet.

Related content which might interest you: Allergic bronchopulmonary aspergillosis and other fungal diseases Source: Eur Respir Mon 2011; 52: 97-114 Year: 2011 Diagnostic value of combined sIgG and sIgE of Aspergillus fumigatus in allergic broncho pulmonary aspergillosis and severe asthma with fungal sensitation Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Peripheral blood eosinophilia and sensitization to Aspergillus fumigatus in adult patients (pts) with non-cystic fibrosis bronchiectasis (B) Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Elevated CEA levels in sera in patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Asthma Year: 2013 Allergic bronchopulmonary aspergillosis (ABPA) by Aspergillus flavus Source: Eur Respir J 2001; 18: Suppl. 33, 218s Year: 2001 Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003 Oct 01;22(4):592-595 Year: 2003 Analogs of Asp f 1 (αsarcin, mitogillin and restrictocin) on the diagnosis and stage assessment of allergic bronchopulmonary aspergillosis Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2008; 31: 36-42 Year: 2008 Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Vitamin D level in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and aspergillus sensitization Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Bronchopulmonary aspergillosis Source: Respipedia Article Year: 2017 Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014